Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway |
| |
摘 要: |
|
收稿时间: | 13 March 2020 |
本文献已被 ScienceDirect 等数据库收录! |
|